944 related articles for article (PubMed ID: 19753515)
1. Inappropriate implantable cardioverter-defibrillator therapy: many causes and many possible solutions.
Zareba W
Cardiol J; 2009; 16(5):391-3. PubMed ID: 19753515
[No Abstract] [Full Text] [Related]
2. Inappropriate cardioverter-defibrillator discharge continues to be a major problem in clinical practice.
Jodko Ł; Kornacewicz-Jach Z; Kaźmierczak J; Rzeuski R; Zielonka J; Kaliszczak R; Safranow K
Cardiol J; 2009; 16(5):432-9. PubMed ID: 19753522
[TBL] [Abstract][Full Text] [Related]
3. Multiple shocks after upgrade of an implantable cardioverter-defibrillator to a cardiac resynchronization therapy-defibrillator device.
Francisco GM; Sharma S; Dougherty AH; Kantharia BK
Cardiol J; 2009; 16(5):473-6. PubMed ID: 19753529
[TBL] [Abstract][Full Text] [Related]
4. Atrial fibrillation in patients with implantable defibrillators.
Sakhuja R; Shah AJ; Keebler M; Thakur RK
Cardiol Clin; 2009 Feb; 27(1):151-61, ix-x. PubMed ID: 19111771
[TBL] [Abstract][Full Text] [Related]
5. Dual-chamber versus single-chamber detection enhancements for implantable defibrillator rhythm diagnosis: the detect supraventricular tachycardia study.
Friedman PA; McClelland RL; Bamlet WR; Acosta H; Kessler D; Munger TM; Kavesh NG; Wood M; Daoud E; Massumi A; Schuger C; Shorofsky S; Wilkoff B; Glikson M
Circulation; 2006 Jun; 113(25):2871-9. PubMed ID: 16769912
[TBL] [Abstract][Full Text] [Related]
6. OptiVol fluid index: does an association with ventricular arrhythmias hold water?
Sullivan RM; Olshansky B
J Cardiovasc Electrophysiol; 2011 Mar; 22(3):300-1. PubMed ID: 21091968
[No Abstract] [Full Text] [Related]
7. Overcoming the defects of a virtue: dual-chamber versus single-chamber detection enhancements for implantable defibrillator rhythm diagnosis: the detect supraventricular tachycardia study.
Sweeney MO
Circulation; 2006 Jun; 113(25):2862-4. PubMed ID: 16801472
[No Abstract] [Full Text] [Related]
8. Should catheter ablation be the preferred therapy for reducing ICD shocks?: Ventricular tachycardia in patients with an implantable defibrillator warrants catheter ablation.
Kuck KH
Circ Arrhythm Electrophysiol; 2009 Dec; 2(6):713-20; discussion 720. PubMed ID: 20009082
[No Abstract] [Full Text] [Related]
9. Atrial fibrillation increases the risk of recurrent ventricular tachyarrhythmias in implantable cardioverter defibrillator recipients.
Rusnak J; Behnes M; Reiser L; Schupp T; Bollow A; Reichelt T; Borggrefe M; Ellguth D; Engelke N; El-Battrawy I; Ansari U; Barre M; Weidner K; Müller J; Barth C; Meininghaus DG; Akin M; Bertsch T; Taton G; Akin I
Arch Cardiovasc Dis; 2021; 114(6-7):443-454. PubMed ID: 33967015
[TBL] [Abstract][Full Text] [Related]
10. Antitachycardia pacing therapy for the successful treatment of lead fracture.
Bhimani AA; Deeprasertkul P; Nannapaneni N; Carayannopoulos GN
J Cardiovasc Electrophysiol; 2015 Feb; 26(2):228-9. PubMed ID: 25354719
[No Abstract] [Full Text] [Related]
11. Ivabradine for the prevention of inappropriate shocks due to sinus tachycardia in patients with an implanted cardioverter defibrillator.
Adler A; Rosso R; Meir I; Viskin S
Europace; 2013 Mar; 15(3):362-5. PubMed ID: 23118003
[TBL] [Abstract][Full Text] [Related]
12. Implantable Cardioverter Defibrillator Programming Characteristics, Shocked Rhythms, and Survival Among Patients Under Thirty Years of Age.
Chang PM; Powell BD; Jones PW; Carter N; Hayes DL; Saxon LA
J Cardiovasc Electrophysiol; 2016 Oct; 27(10):1183-1190. PubMed ID: 27334356
[TBL] [Abstract][Full Text] [Related]
13. SVT discrimination algorithms significantly reduce the rate of inappropriate therapy in the setting of modern-day delayed high-rate detection programming.
Cheng A; Auricchio A; Schloss EJ; Kurita T; Sterns LD; Gerritse B; Brown ML; Fagan DH; Lexcen DR; Ellenbogen KA
J Cardiovasc Electrophysiol; 2019 Dec; 30(12):2877-2884. PubMed ID: 31646695
[TBL] [Abstract][Full Text] [Related]
14. Abdominal submuscular implant of subcutaneous implantable cardioverter-defibrillator in a young child.
Kwok SY; Yam N; Lun KS; Chen RH; Au TW; Yung TC
Europace; 2018 Sep; 20(FI2):f248. PubMed ID: 29401320
[No Abstract] [Full Text] [Related]
15. Wearable cardioverter-defibrillator as a bridge to implantable cardioverter-defibrillator treatment.
Technol Eval Cent Assess Program Exec Summ; 2010 Nov; 25(2):1-5. PubMed ID: 21638938
[No Abstract] [Full Text] [Related]
16. Circadian and seasonal variations of ventricular tachyarrhythmias in patients with early repolarization syndrome and Brugada syndrome: analysis of patients with implantable cardioverter defibrillator.
Kim SH; Nam GB; Baek S; Choi HO; Kim KH; Choi KJ; Joung B; Pak HN; Lee MH; Kim SS; Park SJ; On YK; Kim JS; Oh IY; Choi EK; Oh S; Choi YS; Choi JI; Park SW; Kim YH; Lee MY; Lim HE; Lee YS; Cho Y; Kim J; Lee DI; Cho DK; Kim YH
J Cardiovasc Electrophysiol; 2012 Jul; 23(7):757-63. PubMed ID: 22353358
[TBL] [Abstract][Full Text] [Related]
17. Implantable Cardioverter-Defibrillators and Wearable Defibrillators: Guidelines and Updates.
Mathuria N
Tex Heart Inst J; 2020 Feb; 47(1):51-52. PubMed ID: 32148457
[No Abstract] [Full Text] [Related]
18. Repetitive shock therapy of subcutaneous implantable cardioverter defibrillators in a patient with idiopathic ventricular fibrillation: What is the mechanism?
Hasegawa K; Miyazaki S; Ishikawa E; Mukai M; Aoyama D; Nodera M; Kaseno K; Tada H
J Cardiovasc Electrophysiol; 2019 Oct; 30(10):2121-2124. PubMed ID: 31332856
[No Abstract] [Full Text] [Related]
19. Combining shock reduction strategies to enhance ICD therapy: a role for computer modeling.
Volosin KJ; Exner DV; Wathen MS; Sherfesee L; Scinicariello AP; Gillberg JM
J Cardiovasc Electrophysiol; 2011 Mar; 22(3):280-9. PubMed ID: 20958831
[TBL] [Abstract][Full Text] [Related]
20. Can incremental innovation of implantable cardioverter-defibrillator systems become disruptive to patient care? Moore's law gone awry.
Naccarelli GV
J Cardiovasc Electrophysiol; 2006 Jun; 17(6):621-2. PubMed ID: 16836710
[No Abstract] [Full Text] [Related]
[Next] [New Search]
